333 related articles for article (PubMed ID: 28320424)
21. TREM2-Ligand Interactions in Health and Disease.
Kober DL; Brett TJ
J Mol Biol; 2017 Jun; 429(11):1607-1629. PubMed ID: 28432014
[TBL] [Abstract][Full Text] [Related]
22. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
Keren-Shaul H; Spinrad A; Weiner A; Matcovitch-Natan O; Dvir-Szternfeld R; Ulland TK; David E; Baruch K; Lara-Astaiso D; Toth B; Itzkovitz S; Colonna M; Schwartz M; Amit I
Cell; 2017 Jun; 169(7):1276-1290.e17. PubMed ID: 28602351
[TBL] [Abstract][Full Text] [Related]
23. TREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway.
Zhong L; Zhang ZL; Li X; Liao C; Mou P; Wang T; Wang Z; Wang Z; Wei M; Xu H; Bu G; Chen XF
Front Aging Neurosci; 2017; 9():204. PubMed ID: 28680398
[TBL] [Abstract][Full Text] [Related]
24. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Sims R; van der Lee SJ; Naj AC; Bellenguez C; Badarinarayan N; Jakobsdottir J; Kunkle BW; Boland A; Raybould R; Bis JC; Martin ER; Grenier-Boley B; Heilmann-Heimbach S; Chouraki V; Kuzma AB; Sleegers K; Vronskaya M; Ruiz A; Graham RR; Olaso R; Hoffmann P; Grove ML; Vardarajan BN; Hiltunen M; Nöthen MM; White CC; Hamilton-Nelson KL; Epelbaum J; Maier W; Choi SH; Beecham GW; Dulary C; Herms S; Smith AV; Funk CC; Derbois C; Forstner AJ; Ahmad S; Li H; Bacq D; Harold D; Satizabal CL; Valladares O; Squassina A; Thomas R; Brody JA; Qu L; Sánchez-Juan P; Morgan T; Wolters FJ; Zhao Y; Garcia FS; Denning N; Fornage M; Malamon J; Naranjo MCD; Majounie E; Mosley TH; Dombroski B; Wallon D; Lupton MK; Dupuis J; Whitehead P; Fratiglioni L; Medway C; Jian X; Mukherjee S; Keller L; Brown K; Lin H; Cantwell LB; Panza F; McGuinness B; Moreno-Grau S; Burgess JD; Solfrizzi V; Proitsi P; Adams HH; Allen M; Seripa D; Pastor P; Cupples LA; Price ND; Hannequin D; Frank-García A; Levy D; Chakrabarty P; Caffarra P; Giegling I; Beiser AS; Giedraitis V; Hampel H; Garcia ME; Wang X; Lannfelt L; Mecocci P; Eiriksdottir G; Crane PK; Pasquier F; Boccardi V; Henández I; Barber RC; Scherer M; Tarraga L; Adams PM; Leber M; Chen Y; Albert MS; Riedel-Heller S; Emilsson V; Beekly D; Braae A; Schmidt R; Blacker D; Masullo C; Schmidt H; Doody RS; Spalletta G; Longstreth WT; Fairchild TJ; Bossù P; Lopez OL; Frosch MP; Sacchinelli E; Ghetti B; Yang Q; Huebinger RM; Jessen F; Li S; Kamboh MI; Morris J; Sotolongo-Grau O; Katz MJ; Corcoran C; Dunstan M; Braddel A; Thomas C; Meggy A; Marshall R; Gerrish A; Chapman J; Aguilar M; Taylor S; Hill M; Fairén MD; Hodges A; Vellas B; Soininen H; Kloszewska I; Daniilidou M; Uphill J; Patel Y; Hughes JT; Lord J; Turton J; Hartmann AM; Cecchetti R; Fenoglio C; Serpente M; Arcaro M; Caltagirone C; Orfei MD; Ciaramella A; Pichler S; Mayhaus M; Gu W; Lleó A; Fortea J; Blesa R; Barber IS; Brookes K; Cupidi C; Maletta RG; Carrell D; Sorbi S; Moebus S; Urbano M; Pilotto A; Kornhuber J; Bosco P; Todd S; Craig D; Johnston J; Gill M; Lawlor B; Lynch A; Fox NC; Hardy J; ; Albin RL; Apostolova LG; Arnold SE; Asthana S; Atwood CS; Baldwin CT; Barnes LL; Barral S; Beach TG; Becker JT; Bigio EH; Bird TD; Boeve BF; Bowen JD; Boxer A; Burke JR; Burns JM; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carlsson CM; Carney RM; Carrasquillo MM; Carroll SL; Diaz CC; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; Dick M; Duara R; Evans DA; Faber KM; Fallon KB; Fardo DW; Farlow MR; Ferris S; Foroud TM; Galasko DR; Gearing M; Geschwind DH; Gilbert JR; Graff-Radford NR; Green RC; Growdon JH; Hamilton RL; Harrell LE; Honig LS; Huentelman MJ; Hulette CM; Hyman BT; Jarvik GP; Abner E; Jin LW; Jun G; Karydas A; Kaye JA; Kim R; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lunetta KL; Lyketsos CG; Marson DC; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Morris JC; Murrell JR; Myers AJ; O'Bryant S; Olichney JM; Pankratz VS; Parisi JE; Paulson HL; Perry W; Peskind E; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rogaeva E; Rosen HJ; Rosenberg RN; Sager MA; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Swerdlow RH; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Van Deerlin VM; Van Eldik LJ; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Wilhelmsen KC; Williamson J; Wingo TS; Woltjer RL; Wright CB; Yu CE; Yu L; Garzia F; Golamaully F; Septier G; Engelborghs S; Vandenberghe R; De Deyn PP; Fernadez CM; Benito YA; Thonberg H; Forsell C; Lilius L; Kinhult-Stählbom A; Kilander L; Brundin R; Concari L; Helisalmi S; Koivisto AM; Haapasalo A; Dermecourt V; Fievet N; Hanon O; Dufouil C; Brice A; Ritchie K; Dubois B; Himali JJ; Keene CD; Tschanz J; Fitzpatrick AL; Kukull WA; Norton M; Aspelund T; Larson EB; Munger R; Rotter JI; Lipton RB; Bullido MJ; Hofman A; Montine TJ; Coto E; Boerwinkle E; Petersen RC; Alvarez V; Rivadeneira F; Reiman EM; Gallo M; O'Donnell CJ; Reisch JS; Bruni AC; Royall DR; Dichgans M; Sano M; Galimberti D; St George-Hyslop P; Scarpini E; Tsuang DW; Mancuso M; Bonuccelli U; Winslow AR; Daniele A; Wu CK; ; Peters O; Nacmias B; Riemenschneider M; Heun R; Brayne C; Rubinsztein DC; Bras J; Guerreiro R; Al-Chalabi A; Shaw CE; Collinge J; Mann D; Tsolaki M; Clarimón J; Sussams R; Lovestone S; O'Donovan MC; Owen MJ; Behrens TW; Mead S; Goate AM; Uitterlinden AG; Holmes C; Cruchaga C; Ingelsson M; Bennett DA; Powell J; Golde TE; Graff C; De Jager PL; Morgan K; Ertekin-Taner N; Combarros O; Psaty BM; Passmore P; Younkin SG; Berr C; Gudnason V; Rujescu D; Dickson DW; Dartigues JF; DeStefano AL; Ortega-Cubero S; Hakonarson H; Campion D; Boada M; Kauwe JK; Farrer LA; Van Broeckhoven C; Ikram MA; Jones L; Haines JL; Tzourio C; Launer LJ; Escott-Price V; Mayeux R; Deleuze JF; Amin N; Holmans PA; Pericak-Vance MA; Amouyel P; van Duijn CM; Ramirez A; Wang LS; Lambert JC; Seshadri S; Williams J; Schellenberg GD
Nat Genet; 2017 Sep; 49(9):1373-1384. PubMed ID: 28714976
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
[TBL] [Abstract][Full Text] [Related]
26. Expression of GPR17, a regulator of oligodendrocyte differentiation and maturation, in Nasu-Hakola disease brains.
Satoh JI; Kino Y; Yanaizu M; Tosaki Y; Sakai K; Ishida T; Saito Y
Intractable Rare Dis Res; 2017 Feb; 6(1):50-54. PubMed ID: 28357182
[TBL] [Abstract][Full Text] [Related]
27. TREM2 in Neurodegenerative Diseases.
Jay TR; von Saucken VE; Landreth GE
Mol Neurodegener; 2017 Aug; 12(1):56. PubMed ID: 28768545
[TBL] [Abstract][Full Text] [Related]
28. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.
Efthymiou AG; Goate AM
Mol Neurodegener; 2017 May; 12(1):43. PubMed ID: 28549481
[TBL] [Abstract][Full Text] [Related]
29. TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.
Zhao Y; Wu X; Li X; Jiang LL; Gui X; Liu Y; Sun Y; Zhu B; Piña-Crespo JC; Zhang M; Zhang N; Chen X; Bu G; An Z; Huang TY; Xu H
Neuron; 2018 Mar; 97(5):1023-1031.e7. PubMed ID: 29518356
[TBL] [Abstract][Full Text] [Related]
30. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
[TBL] [Abstract][Full Text] [Related]
31. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
[TBL] [Abstract][Full Text] [Related]
32. A Tale of Two Genes: Microglial Apoe and Trem2.
Pimenova AA; Marcora E; Goate AM
Immunity; 2017 Sep; 47(3):398-400. PubMed ID: 28930654
[TBL] [Abstract][Full Text] [Related]
33. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
[TBL] [Abstract][Full Text] [Related]
34. Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.
Gonzalez B; Abud EM; Abud AM; Poon WW; Gylys KH
Neurol Clin; 2017 May; 35(2):175-190. PubMed ID: 28410655
[TBL] [Abstract][Full Text] [Related]
35. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.
Shinohara M; Tachibana M; Kanekiyo T; Bu G
J Lipid Res; 2017 Jul; 58(7):1267-1281. PubMed ID: 28381441
[TBL] [Abstract][Full Text] [Related]
36. Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's disease.
Bonham LW; Sirkis DW; Fan J; Aparicio RE; Tse M; Ramos EM; Wang Q; Coppola G; Rosen HJ; Miller BL; Yokoyama JS
Neurocase; 2017 Feb; 23(1):65-69. PubMed ID: 28376694
[TBL] [Abstract][Full Text] [Related]
37. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.
Abud EM; Ramirez RN; Martinez ES; Healy LM; Nguyen CHH; Newman SA; Yeromin AV; Scarfone VM; Marsh SE; Fimbres C; Caraway CA; Fote GM; Madany AM; Agrawal A; Kayed R; Gylys KH; Cahalan MD; Cummings BJ; Antel JP; Mortazavi A; Carson MJ; Poon WW; Blurton-Jones M
Neuron; 2017 Apr; 94(2):278-293.e9. PubMed ID: 28426964
[TBL] [Abstract][Full Text] [Related]
38. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
39. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
[TBL] [Abstract][Full Text] [Related]
40. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.
Lee CYD; Daggett A; Gu X; Jiang LL; Langfelder P; Li X; Wang N; Zhao Y; Park CS; Cooper Y; Ferando I; Mody I; Coppola G; Xu H; Yang XW
Neuron; 2018 Mar; 97(5):1032-1048.e5. PubMed ID: 29518357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
